These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile. Paiva B; Paino T; Sayagues JM; Garayoa M; San-Segundo L; Martín M; Mota I; Sanchez ML; Bárcena P; Aires-Mejia I; Corchete L; Jimenez C; Garcia-Sanz R; Gutierrez NC; Ocio EM; Mateos MV; Vidriales MB; Orfao A; San Miguel JF Blood; 2013 Nov; 122(22):3591-8. PubMed ID: 24072855 [TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel. Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930 [TBL] [Abstract][Full Text] [Related]
5. Clinical and biological significance of circulating tumor cells in cancer. Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533 [TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Garcés JJ; Cedena MT; Puig N; Burgos L; Perez JJ; Cordon L; Flores-Montero J; Sanoja-Flores L; Calasanz MJ; Ortiol A; Blanchard MJ; Rios R; Martin J; Martínez-Martinez R; Bargay J; Sureda A; de la Rubia J; Hernandez MT; Rodriguez-Otero P; de la Cruz J; Orfao A; Mateos MV; Martinez-Lopez J; Lahuerta JJ; Rosiñol L; Blade J; San-Miguel JF; Paiva B J Clin Oncol; 2022 Sep; 40(27):3151-3161. PubMed ID: 35666958 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features. Azab AK; Hu J; Quang P; Azab F; Pitsillides C; Awwad R; Thompson B; Maiso P; Sun JD; Hart CP; Roccaro AM; Sacco A; Ngo HT; Lin CP; Kung AL; Carrasco RD; Vanderkerken K; Ghobrial IM Blood; 2012 Jun; 119(24):5782-94. PubMed ID: 22394600 [TBL] [Abstract][Full Text] [Related]
8. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy. Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521 [TBL] [Abstract][Full Text] [Related]
9. Adhesion molecule immunophenotype of bone marrow multiple myeloma plasma cells impacts the presence of malignant circulating plasma cells in peripheral blood. Klimienė I; Radzevičius M; Matuzevičienė R; Sinkevič-Belliot K; Kučinskienė ZA; Pečeliūnas V Int J Lab Hematol; 2021 Jun; 43(3):403-408. PubMed ID: 33185981 [TBL] [Abstract][Full Text] [Related]
10. Genetic interrogation of circulating multiple myeloma cells at single-cell resolution. Lohr JG; Kim S; Gould J; Knoechel B; Drier Y; Cotton MJ; Gray D; Birrer N; Wong B; Ha G; Zhang CZ; Guo G; Meyerson M; Yee AJ; Boehm JS; Raje N; Golub TR Sci Transl Med; 2016 Nov; 8(363):363ra147. PubMed ID: 27807282 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes. Binder M; Szalat RE; Talluri S; Fulciniti M; Avet-Loiseau H; Parmigiani G; Samur MK; Munshi NC Nat Commun; 2024 May; 15(1):4139. PubMed ID: 38755155 [TBL] [Abstract][Full Text] [Related]
12. MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology. Dutta AK; Alberge JB; Lightbody ED; Boehner CJ; Dunford A; Sklavenitis-Pistofidis R; Mouhieddine TH; Cowan AN; Su NK; Horowitz EM; Barr H; Hevenor L; Beckwith JB; Perry J; Cao A; Lin Z; Kuhr FK; Mastro RGD; Nadeem O; Greipp PT; Stewart C; Auclair D; Getz G; Ghobrial IM Cancer Discov; 2023 Feb; 13(2):348-363. PubMed ID: 36477267 [TBL] [Abstract][Full Text] [Related]
13. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells. Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917 [TBL] [Abstract][Full Text] [Related]
14. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662 [TBL] [Abstract][Full Text] [Related]
15. Transcription phenotype of circulating tumor cells in non-metastatic breast cancer. Shliakhtunou YA; Siamionau VM; Pobyarzhin VV Carcinogenesis; 2022 Feb; 43(1):21-27. PubMed ID: 34919653 [TBL] [Abstract][Full Text] [Related]
16. The microenvironment and molecular biology of the multiple myeloma tumor. Lemaire M; Deleu S; De Bruyne E; Van Valckenborgh E; Menu E; Vanderkerken K Adv Cancer Res; 2011; 110():19-42. PubMed ID: 21704227 [TBL] [Abstract][Full Text] [Related]
17. Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer. Pore M; Meijer C; de Bock GH; Boersma-van Ek W; Terstappen LW; Groen HJ; Timens W; Kruyt FA; Hiltermann TJ Clin Lung Cancer; 2016 Nov; 17(6):535-542. PubMed ID: 27363902 [TBL] [Abstract][Full Text] [Related]
18. Association between BRAF expression in circulating tumor cells and the clinical feature of patients with multiple myeloma. Tang JX; Zhang JH; Zhou KB; Li WT; Wang JY; Li Q; Yan FX; Xiao D Neoplasma; 2022 Sep; 69(5):1228-1236. PubMed ID: 35951455 [TBL] [Abstract][Full Text] [Related]